1,3-dipropyl-8-cyclopentylxanthine has been researched along with Elevated Cholesterol in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donato, M | 1 |
| D'Annunzio, V | 1 |
| Berg, G | 1 |
| Gonzalez, G | 1 |
| Schreier, L | 1 |
| Morales, C | 1 |
| Wikinski, RL | 1 |
| Gelpi, RJ | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Elevated Cholesterol
| Article | Year |
|---|---|
Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits.
Topics: Adenosine A1 Receptor Antagonists; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Coronary C | 2007 |